Aperio Group LLC Acquires 5,516 Shares of The Clorox Company (CLX)

Aperio Group LLC lifted its holdings in The Clorox Company (NYSE:CLX) by 3.9% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 148,070 shares of the company’s stock after acquiring an additional 5,516 shares during the quarter. Aperio Group LLC’s holdings in The Clorox were worth $19,710,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in CLX. Two Sigma Advisers LP grew its position in shares of The Clorox by 331.4% in the 4th quarter. Two Sigma Advisers LP now owns 815,434 shares of the company’s stock worth $121,288,000 after buying an additional 626,426 shares during the period. APG Asset Management N.V. grew its position in shares of The Clorox by 38.6% in the 4th quarter. APG Asset Management N.V. now owns 1,804,215 shares of the company’s stock worth $223,483,000 after buying an additional 502,300 shares during the period. Renaissance Technologies LLC grew its position in shares of The Clorox by 15.1% in the 4th quarter. Renaissance Technologies LLC now owns 2,360,600 shares of the company’s stock worth $351,116,000 after buying an additional 310,000 shares during the period. Schroder Investment Management Group grew its position in shares of The Clorox by 197.4% in the 4th quarter. Schroder Investment Management Group now owns 461,861 shares of the company’s stock worth $68,697,000 after buying an additional 306,557 shares during the period. Finally, Amundi Pioneer Asset Management Inc. grew its position in shares of The Clorox by 196.0% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 430,313 shares of the company’s stock worth $64,005,000 after buying an additional 284,937 shares during the period. 76.39% of the stock is currently owned by hedge funds and other institutional investors.

Shares of The Clorox opened at $118.33 on Friday, according to MarketBeat.com. The company has a current ratio of 1.18, a quick ratio of 0.93 and a debt-to-equity ratio of 2.14. The stock has a market cap of $15.20 billion, a PE ratio of 22.12, a P/E/G ratio of 2.63 and a beta of 0.37. The Clorox Company has a 52-week low of $117.44 and a 52-week high of $118.56.

The Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, May 2nd. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The firm had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.51 billion. The Clorox had a net margin of 13.27% and a return on equity of 107.93%. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm posted $1.31 EPS. equities research analysts forecast that The Clorox Company will post 5.73 earnings per share for the current fiscal year.

CLX has been the topic of several recent analyst reports. Zacks Investment Research downgraded shares of The Clorox from a “hold” rating to a “sell” rating in a research report on Monday, April 9th. Morgan Stanley downgraded shares of The Clorox from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $126.72 to $116.00 in a research report on Thursday, April 19th. They noted that the move was a valuation call. Barclays set a $131.00 price objective on shares of The Clorox and gave the company a “hold” rating in a research report on Friday, April 6th. Argus downgraded shares of The Clorox from a “buy” rating to a “hold” rating and cut their price objective for the company from $150.40 to $127.81 in a research report on Thursday, February 8th. Finally, JPMorgan Chase reissued a “neutral” rating and set a $138.00 price objective (down from $139.00) on shares of The Clorox in a research report on Tuesday, March 13th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. The Clorox presently has a consensus rating of “Hold” and an average target price of $130.98.

About The Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply